{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:08:13Z","timestamp":1785902893059,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Accumulating evidence indicates that long non-coding RNAs (lncRNAs) acting as crucial regulators in tumorigenesis. However, its biological functions of lncRNAs in colorectal cancer (CRC) have not been systematically clarified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An unbiased screening was performed to identify disregulated lncRNAs revealed to be implicated in CRC carcinogenesis according to an online-available data dataset. In situ hybridization (ISH), RT-qPCR and RNA fluorescence in situ hybridization (RNA-FISH) were applied to detect RP11-757G1.5 expression in CRC tissues and cell lines. The associations of RP11-757G1.5 with clinicopathological characteristics were analyzed. Their effects on prognosis were analyzed by the Kaplan-Meier analysis, Log-rank test, Univariate and Multivariate Cox regression analysis. The potential biological function of RP11-757G1.5 in CRC was investigated by Colony formation, Edu cell proliferation, Flow cytometry, Wound healing and Transwell assays. Bioinformatics binding site analysis, Luciferase reporter assay, Ago2 immunoprecipitation assays, RNA pull-down assay, RT-qPCR and Western blotting were utilized to demonstrate the mechanism of RP11-757G1.5 acts as a molecular sponge of miR-139-5p to regulate the expression of YAP1. Finally, we further explore the potential role of RP11-757G1.5 in CRC orthotopic xenografts in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We discovered a novel oncogenic lncRNA RP11-757G1.5, that was overexpressed in CRC tissues, especially in aggressive cases. Moreover, up-regulation of RP11-757G1.5 strongly correlated with poor clinical outcomes of patients with CRC. Functional analyses revealed that RP11-757G1.5 promoted cell proliferation in vitro and in vivo. Furthermore, RP11-757G1.5 stimulated cell migration and invasion in vitro and in vivo. Mechanistic studies illustrated that RP11-757G1.5 regulated the expression of YAP1 through sponging miR-139-5p and inhibiting its activity thereby promoting CRC progression and development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Altogether, these results reveal a novel RP11-757G1.5\/miR-139-5p\/YAP1 regulatory axis that participates in CRC carcinogenesis and progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-020-01717-5","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T16:02:52Z","timestamp":1602000172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer"],"prefix":"10.1186","volume":"39","author":[{"given":"Xiaojian","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanqin","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"issue":"1","key":"1717_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"R Siegel","year":"2019","unstructured":"Siegel R, Miller K, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1717_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade P, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"1717_CR3","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/1873-3468.12655","volume":"591","author":"S Singh","year":"2017","unstructured":"Singh S, Chouhan S, Mohammad N, Bhat M. Resistin causes G1 arrest in colon cancer cells through upregulation of SOCS3. FEBS Lett. 2017;591(10):1371\u201382.","journal-title":"FEBS Lett"},{"key":"1717_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40170-018-0176-5","volume":"6","author":"P Malvi","year":"2018","unstructured":"Malvi P, Chaube B, Singh S, Mohammad N, Vijayakumar M, Singh S, et al. Elevated circulatory levels of leptin and resistin impair therapeutic efficacy of dacarbazine in melanoma under obese state. Cancer & metabolism. 2018;6:2.","journal-title":"Cancer & metabolism"},{"key":"1717_CR5","doi-asserted-by":"publisher","first-page":"11853","DOI":"10.1038\/srep11853","volume":"5","author":"N Mohammad","year":"2015","unstructured":"Mohammad N, Singh S, Malvi P, Chaube B, Athavale D, Vanuopadath M, et al. Strategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-\u03b2-cyclodextrin: involvement of p53 and Fas receptor ligand complex. Sci Rep. 2015;5:11853.","journal-title":"Sci Rep"},{"key":"1717_CR6","doi-asserted-by":"publisher","first-page":"e1934","DOI":"10.1038\/cddis.2015.292","volume":"6","author":"S Singh","year":"2015","unstructured":"Singh S, Ajay A, Mohammad N, Malvi P, Chaube B, Meena A, et al. Proteasomal inhibition sensitizes cervical cancer cells to mitomycin C-induced bystander effect: the role of tumor microenvironment. Cell Death Dis. 2015;6:e1934.","journal-title":"Cell Death Dis"},{"issue":"13","key":"1717_CR7","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1158\/0008-5472.CAN-18-4044","volume":"79","author":"T Lan","year":"2019","unstructured":"Lan T, Yuan K, Yan X, Xu L, Liao H, Hao X, et al. LncRNA SNHG10 facilitates Hepatocarcinogenesis and metastasis by modulating its homolog SCARNA13 via a positive feedback loop. Cancer Res. 2019;79(13):3220\u201334.","journal-title":"Cancer Res"},{"issue":"1","key":"1717_CR8","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1038\/s41467-019-11447-8","volume":"10","author":"J Tang","year":"2019","unstructured":"Tang J, Yan T, Bao Y, Shen C, Yu C, Zhu X, et al. LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc. Nat Commun. 2019;10(1):3499.","journal-title":"Nat Commun"},{"issue":"1","key":"1717_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12943-019-1032-0","volume":"18","author":"C Wang","year":"2019","unstructured":"Wang C, Zhu C, Xu J, Wang M, Zhao W, Liu Q, et al. The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs. Mol Cancer. 2019;18(1):115.","journal-title":"Mol Cancer"},{"key":"1717_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-014-0090-4","volume":"7","author":"G Loewen","year":"2014","unstructured":"Loewen G, Jayawickramarajah J, Zhuo Y, Shan B. Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol. 2014;7:90.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1717_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12943-018-0897-7","volume":"17","author":"Z Sun","year":"2018","unstructured":"Sun Z, Shi K, Yang S, Liu J, Zhou Q, Wang G, et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer. 2018;17(1):147.","journal-title":"Mol Cancer"},{"key":"1717_CR12","doi-asserted-by":"publisher","first-page":"6357","DOI":"10.1126\/science.aam8526","volume":"357","author":"M Piwecka","year":"2017","unstructured":"Piwecka M, Gla\u017ear P, Hernandez-Miranda L, Memczak S, Wolf S, Rybak-Wolf A, et al. Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function. Science (New York, N.Y.). 2017;357:6357.","journal-title":"Science (New York, N.Y.)"},{"issue":"36","key":"1717_CR13","doi-asserted-by":"publisher","first-page":"58595","DOI":"10.18632\/oncotarget.11193","volume":"7","author":"N Muhammad","year":"2016","unstructured":"Muhammad N, Bhattacharya S, Steele R, Ray R. Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3. Oncotarget. 2016;7(36):58595\u2013605.","journal-title":"Oncotarget."},{"issue":"26","key":"1717_CR14","doi-asserted-by":"publisher","first-page":"8206","DOI":"10.7150\/thno.37455","volume":"9","author":"L He","year":"2019","unstructured":"He L, Zhu W, Chen Q, Yuan Y, Wang Y, Wang J, et al. Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis. Theranostics. 2019;9(26):8206\u201320.","journal-title":"Theranostics."},{"issue":"11","key":"1717_CR15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41389-017-0008-4","volume":"6","author":"Z Bian","year":"2017","unstructured":"Bian Z, Zhang J, Li M, Feng Y, Yao S, Song M, et al. Long non-coding RNA LINC00152 promotes cell proliferation, metastasis, and confers 5-FU resistance in colorectal cancer by inhibiting miR-139-5p. Oncogenesis. 2017;6(11):395.","journal-title":"Oncogenesis."},{"issue":"16","key":"1717_CR16","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1111\/febs.12880","volume":"281","author":"K Shen","year":"2014","unstructured":"Shen K, Mao R, Ma L, Li Y, Qiu Y, Cui D, et al. Post-transcriptional regulation of the tumor suppressor miR-139-5p and a network of miR-139-5p-mediated mRNA interactions in colorectal cancer. FEBS J. 2014;281(16):3609\u201324.","journal-title":"FEBS J"},{"key":"1717_CR17","doi-asserted-by":"crossref","unstructured":"Cao B, Wang K, Liao J, Zhou X, Liao P, Zeng S, et al. Inactivation of oncogenic cAMP-specific phosphodiesterase 4D by miR-139-5p in response to p53 activation. eLife. 2016;5.","DOI":"10.7554\/eLife.15978"},{"issue":"12","key":"1717_CR18","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/s41388-017-0057-3","volume":"37","author":"S Hua","year":"2018","unstructured":"Hua S, Lei L, Deng L, Weng X, Liu C, Qi X, et al. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1. Oncogene. 2018;37(12):1624\u201336.","journal-title":"Oncogene."},{"issue":"6","key":"1717_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12510","volume":"51","author":"J Chen","year":"2018","unstructured":"Chen J, Yu Y, Chen X, He Y, Hu Q, Li H, et al. MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma. Cell Prolif. 2018;51(6):e12510.","journal-title":"Cell Prolif"},{"key":"1717_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1476-4598-13-124","volume":"13","author":"L Zhang","year":"2014","unstructured":"Zhang L, Dong Y, Zhu N, Tsoi H, Zhao Z, Wu C, et al. microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer. Mol Cancer. 2014;13:124.","journal-title":"Mol Cancer"},{"issue":"2","key":"1717_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5582\/bst.2019.01272","volume":"14","author":"X Zhu","year":"2020","unstructured":"Zhu X, Luo C, Lin K, Bu F, Ye F, Huang C, et al. Overexpression of DJ-1 enhances colorectal cancer cell proliferation through the cyclin-D1\/MDM2-p53 signaling pathway. Bioscience Trends. 2020;14(2):83\u201395.","journal-title":"Bioscience Trends"},{"key":"1717_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fonc.2020.00160","volume":"10","author":"X Dong","year":"2020","unstructured":"Dong X, Yang Z, Yang H, Li D, Qiu X. Long non-coding RNA MIR4435-2HG promotes colorectal Cancer proliferation and metastasis through miR-206\/YAP1 Axis. Front Oncol. 2020;10:160.","journal-title":"Front Oncol"},{"issue":"18","key":"1717_CR23","doi-asserted-by":"publisher","first-page":"7357","DOI":"10.18632\/aging.102214","volume":"11","author":"X Xu","year":"2019","unstructured":"Xu X, Chen X, Xu M, Liu X, Pan B, Qin J, et al. miR-375-3p suppresses tumorigenesis and partially reverses chemoresistance by targeting YAP1 and SP1 in colorectal cancer cells. Aging. 2019;11(18):7357\u201385.","journal-title":"Aging."},{"key":"1717_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.canlet.2017.04.011","volume":"399","author":"C Ou","year":"2017","unstructured":"Ou C, Sun Z, Li X, Li X, Ren W, Qin Z, et al. MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer. Cancer Lett. 2017;399:53\u201363.","journal-title":"Cancer Lett"},{"issue":"3","key":"1717_CR25","first-page":"1901380","volume":"7","author":"C Ou","year":"2020","unstructured":"Ou C, Sun Z, He X, Li X, Fan S, Zheng X, et al. Targeting YAP1\/LINC00152\/FSCN1 Signaling Axis Prevents the Progression of Colorectal Cancer. Advanced Sci (Weinheim, Baden-Wurttemberg, Germany). 2020;7(3):1901380.","journal-title":"Advanced Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"14","key":"1717_CR26","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1038\/s41388-018-0628-y","volume":"38","author":"Z Sun","year":"2019","unstructured":"Sun Z, Ou C, Liu J, Chen C, Zhou Q, Yang S, et al. YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer. Oncogene. 2019;38(14):2627\u201344.","journal-title":"Oncogene."},{"key":"1717_CR27","doi-asserted-by":"publisher","first-page":"43393","DOI":"10.1038\/srep43393","volume":"7","author":"J Miyoshi","year":"2017","unstructured":"Miyoshi J, Toden S, Yoshida K, Toiyama Y, Alberts S, Kusunoki M, et al. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer. Sci Rep. 2017;7:43393.","journal-title":"Sci Rep"},{"issue":"22","key":"1717_CR28","doi-asserted-by":"publisher","first-page":"10631","DOI":"10.1093\/nar\/gkw802","volume":"44","author":"M Kalwa","year":"2016","unstructured":"Kalwa M, H\u00e4nzelmann S, Otto S, Kuo C, Franzen J, Joussen S, et al. The lncRNA HOTAIR impacts on mesenchymal stem cells via triple helix formation. Nucleic Acids Res. 2016;44(22):10631\u201343.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"1717_CR29","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1158\/0008-5472.CAN-18-2170","volume":"79","author":"D Voce","year":"2019","unstructured":"Voce D, Bernal G, Wu L, Crawley C, Zhang W, Mansour N, et al. Temozolomide treatment induces lncRNA MALAT1 in an NF-\u03baB and p53 codependent manner in Glioblastoma. Cancer Res. 2019;79(10):2536\u201348.","journal-title":"Cancer Res"},{"issue":"15","key":"1717_CR30","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.117.032184","volume":"138","author":"D Li","year":"2018","unstructured":"Li D, Busch A, Jin H, Chernogubova E, Pelisek J, Karlsson J, et al. H19 induces abdominal aortic aneurysm development and progression. Circulation. 2018;138(15):1551\u201368.","journal-title":"Circulation."},{"issue":"1","key":"1717_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12943-018-0837-6","volume":"17","author":"Y Wang","year":"2018","unstructured":"Wang Y, Zeng X, Wang N, Zhao W, Zhang X, Teng S, et al. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma. Mol Cancer. 2018;17(1):89.","journal-title":"Mol Cancer"},{"issue":"1","key":"1717_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-019-0957-7","volume":"18","author":"Y Wang","year":"2019","unstructured":"Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu Q, et al. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p\/FOXA1 axis. Mol Cancer. 2019;18(1):28.","journal-title":"Mol Cancer"},{"issue":"16","key":"1717_CR33","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.7150\/thno.18990","volume":"7","author":"Y Du","year":"2017","unstructured":"Du Y, Tu G, Yang G, Li G, Yang D, Lang L, et al. MiR-205\/YAP1 in activated fibroblasts of breast tumor promotes VEGF-independent angiogenesis through STAT3 signaling. Theranostics. 2017;7(16):3972\u201388.","journal-title":"Theranostics."},{"issue":"1","key":"1717_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12943-016-0556-9","volume":"15","author":"Y Wang","year":"2016","unstructured":"Wang Y, Lieberman R, Pan J, Zhang Q, Du M, Zhang P, et al. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1. Molecular cancer. 2016;15(1):70.","journal-title":"Molecular cancer"},{"issue":"33","key":"1717_CR35","doi-asserted-by":"publisher","first-page":"34658","DOI":"10.18632\/oncotarget.5778","volume":"6","author":"J Park","year":"2015","unstructured":"Park J, Jeong S. Wnt activated \u03b2-catenin and YAP proteins enhance the expression of non-coding RNA component of RNase MRP in colon cancer cells. Oncotarget. 2015;6(33):34658\u201368.","journal-title":"Oncotarget."},{"issue":"40","key":"1717_CR36","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1038\/onc.2013.433","volume":"33","author":"L Chan","year":"2014","unstructured":"Chan L, Wang W, Yeung W, Deng Y, Yuan P, Mak K. Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression. Oncogene. 2014;33(40):4857\u201366.","journal-title":"Oncogene."},{"issue":"5","key":"1717_CR37","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/hep.29316","volume":"66","author":"Y Gao","year":"2017","unstructured":"Gao Y, Feng J, Yang G, Zhang S, Liu Y, Bu Y, et al. Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis. Hepatology (Baltimore, Md.). 2017;66(5):1413\u201329.","journal-title":"Hepatology (Baltimore, Md.)"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-020-01717-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-020-01717-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-020-01717-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T03:57:14Z","timestamp":1633492634000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-020-01717-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1717"],"URL":"https:\/\/doi.org\/10.1186\/s13046-020-01717-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-25530\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-25530\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-25530\/v1","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]},"assertion":[{"value":"1 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee of the Second Affiliated Hospital of Nanchang University reviewed and approved all research procedures involving human or animal participants. All patients expressed informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The all authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"207"}}